By Devika Patel
Knoxville, Tenn., Jan. 28 - Exact Sciences Corp. settled a $6 million private placement of stock on Jan. 27, according to an 8-K filed Wednesday with the Securities and Exchange Commission.
The company sold 3 million shares at $2.00 apiece to Genzyme Corp.
Exact Sciences, based in Marlborough, Mass., develops screening technologies for cancer detection.
| Issuer: | Exact Sciences Corp.
|
| Issue: | Common stock
|
| Amount: | $6 million
|
| Shares: | 3 million
|
| Price: | $2.00
|
| Warrants: | No
|
| Investor: | Genzyme Corp.
|
| Settlement date: | Jan. 27
|
| Stock symbol: | Nasdaq: EXAS
|
| Stock price: | $1.49 at close Jan. 27
|
| Market capitalization: | $45 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
